+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infantile Spasms Therapeutics Market Research Report by Dosage (Liquid and Solid), Route of Administration, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 227 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4904865
UP TO OFF until Dec 31st 2022
The Global Infantile Spasms Therapeutics Market size was estimated at USD 338.29 million in 2021, USD 359.16 million in 2022, and is projected to grow at a CAGR 6.34% to reach USD 489.30 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Infantile Spasms Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Dosage, the market was studied across Liquid and Solid.
  • Based on Route of Administration, the market was studied across Oral and Parental.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Infantile Spasms Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Infantile Spasms Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Infantile Spasms Therapeutics Market, including Anavex Life Sciences Corp, CatalystPharma, Etrophin, Inc., Gw Pharmaceuticals, Gw Pharmaceuticals, Plc., H. Lundbeck A/S, Insys Therapeutics Inc., Mallinckrodt Pharmaceuticals, MSN Laboratories Private Limited, ORPHELIA Pharma SA, Retrophin, Inc., and Valerion Therapeutics.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Infantile Spasms Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Infantile Spasms Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Infantile Spasms Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Infantile Spasms Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Infantile Spasms Therapeutics Market?
6. What is the market share of the leading vendors in the Global Infantile Spasms Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Infantile Spasms Therapeutics Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of central nervous system (CNS) infection
5.1.1.2. Rising penetration rate of infantile spasm drugs
5.1.1.3. Awareness by government and private organizations to decrease the number of undiagnosed cases
5.1.2. Restraints
5.1.2.1. High cost of treatment and lack of proper diagnosis of infantile spasm
5.1.3. Opportunities
5.1.3.1. Expanding scientific advancements in the treatment for infantile spasms
5.1.3.2. Increasing extensive research and development activities
5.1.4. Challenges
5.1.4.1. Stringent regulations for drug approval
5.2. Cumulative Impact of COVID-19
6. Infantile Spasms Therapeutics Market, by Dosage
6.1. Introduction
6.2. Liquid
6.3. Solid
7. Infantile Spasms Therapeutics Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parental
8. Americas Infantile Spasms Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Infantile Spasms Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Infantile Spasms Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Anavex Life Sciences Corp
12.2. CatalystPharma
12.3. Etrophin, Inc.
12.4. Gw Pharmaceuticals
12.5. Gw Pharmaceuticals, Plc.
12.6. H. Lundbeck A/S
12.7. Insys Therapeutics Inc.
12.8. Mallinckrodt Pharmaceuticals
12.9. MSN Laboratories Private Limited
12.10. ORPHELIA Pharma SA
12.11. Retrophin, Inc.
12.12. Valerion Therapeutics
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET DYNAMICS
FIGURE 8. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2027
FIGURE 11. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 18. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 24. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 26. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 32. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2027
FIGURE 34. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 36. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 38. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 65. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 31. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 33. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 34. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 36. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 37. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 39. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 40. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 42. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 51. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 53. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 54. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 56. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 57. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 59. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 60. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 62. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 63. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 65. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 66. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 68. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 69. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 71. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 72. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 74. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 75. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 77. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 78. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 80. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 81. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 83. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 88. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 90. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 91. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 93. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 94. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 96. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 97. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 99. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 100. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 102. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 103. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 105. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 106. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 108. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 109. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 111. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 112. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 114. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 118. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 119. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 120. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 121. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 122. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 123. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 124. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET RANKING
TABLE 125. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 126. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 127. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 130. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 131. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Anavex Life Sciences Corp
  • CatalystPharma
  • Etrophin, Inc.
  • Gw Pharmaceuticals
  • Gw Pharmaceuticals, Plc.
  • H. Lundbeck A/S
  • Insys Therapeutics Inc.
  • Mallinckrodt Pharmaceuticals
  • MSN Laboratories Private Limited
  • ORPHELIA Pharma SA
  • Retrophin, Inc.
  • Valerion Therapeutics

Methodology

Loading
LOADING...